Amgen had 16 patents in future of work during Q4 2023. Amgen Inc has filed patents for automated systems for low-pH viral inactivation, a robotic inspection platform for container inspection, and methods for determining the minimum number of cell line clones needed to produce a product with specific attributes. These innovations aim to improve efficiency and accuracy in biopharmaceutical manufacturing processes. GlobalData’s report on Amgen gives a 360-degreee view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData


Data Insights Amgen Inc - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

Amgen grant share with future of work as a theme is 31% in Q4 2023. Grant share is based on the ratio of number of grants to total number of patents.

Recent Patents

Application: In-process verification of calibration status of ph probes (Patent ID: US20230416667A1)

The patent filed by Amgen Inc. describes an automated system and method for low-pH viral inactivation. The system involves transferring an elution pool to a first vessel with acid, monitoring the pH levels, transferring the pool to a second vessel for virus reduction, neutralization, filtration, and transfer to a third vessel. The system also includes recalibration checks using known-pH buffers and alerts for any discrepancies in pH values.

The automated system includes various components such as vessels, pH probes, acid pumps, transfer pumps, buffer pumps, alert generators, base pumps, discharge pumps, and collection pumps to facilitate the process of low-pH viral inactivation. The system ensures efficient monitoring and control of pH levels throughout the inactivation process, with alerts generated in case of any deviations. Additionally, the system allows for the use of equilibration buffers with known pH values for recalibration purposes, ensuring the accuracy and effectiveness of the viral inactivation process.

To know more about GlobalData’s detailed insights on Amgen, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.